Healthcare -
Biotechnology - NASDAQ - US
$ 327.615
-4 %
$ 7.23 B
Market Cap
-14.96
P/E
Price Target
Average
15.72%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
25.99%
Net Income
Estimate
68.70%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Madrigal Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for MDGL of $379 , with forecasts ranging from
a
low of
$270 to a high of $425 .
MDGL Lowest Price Target
Wall Street Target
270 USD
-17.59%
MDGL Average Price Target
Wall Street Target
379 USD
15.72%
MDGL Highest Price Target
Wall Street Target
425 USD
29.73%
REVENUE FORECAST
Revenue Forecast Chart MDGL
EBIT FORECAST
EBIT Forecast Chart MDGL
NET INCOME FORECAST
Net Income Chart MDGL